Difference between revisions of "Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Has Sectioning (P146): References (from DOI: 10.1007/s11886-020-01292-3) (Q10743), #quickstatements; #temporary_batch_1592944510830)
(‎Created claim: named entity (P78): COVID-19 (disease - MeSH supplementary concept) (Q7804), #quickstatements; #temporary_batch_1592945455790)
Property / named entity
 +
Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank
 +
Normal rank

Revision as of 20:50, 23 June 2020

Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3
Language Label Description Also known as
English
Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3)
Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3

    Statements